Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-07

Clinical Trial Update: Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer [Phase 1]

View source ↗

Summary

This is a Phase 1 trial evaluating chemotherapy in combination with amifostine and filgrastim in patients with recurrent or metastatic cancer. The conditions in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amifostine (amifostine)
  • Filgrastim (filgrastim)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Leukemia, Lymphoma | Phase 1 | Status: COMPLETED